Nightstar Therapeutics Plc (NITE) Return on Equity ROE from the first quarter 2019 to first quarter 2018 and annually, average high and low, overall ranking from Mar 31 2019 to Mar 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nightstar Therapeutics Plc  (NITE)

Nightstar Therapeutics Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Nightstar Therapeutics Plc in the first quarter 2019?
Nightstar Therapeutics Plc recorded a cumulative net loss of $-39 million during 12 months ending in the first quarter 2019, resulting in a negative return on equity (ROE) of -29.69%.

Within the Biotechnology & Pharmaceuticals industry 32 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2018 from 0 to 3468.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Equity Change 19 % 31.65 % -20.77 % -13.31 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -39 -37 -42 -44 -41
Return On Equity (TTM) -29.69 % -29.48 % -36.72 % -36.54 % -32.25 %
NITE's Total Ranking # 3468 # 0 # 0 # 0 #
Equity (TTM) in Millions 150 166 100 109 126
Seq. Equity Change -9.61 % 66.17 % -8.61 % -13.31 % 0 %
Seq. Net Income Change - - - - -

Back to NITE Management Effectiveness >> NITE's 5 Years Annual ROE >> Compare NITE ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 33
Sector # 330
Overall # 3468

Return On Equity Statistics
High Average Low
-23.6 %
-39.15 %
-53.22 %
(Dec 31 2017)   (Dec 31 2018)





NITE Annual Return On Equity (Dec 31 2018)
2018		 (Dec 31 2017)
2017


Total Equity in Millions 166 126 0 0 0
Y / Y Equity Change 31.65 % - - - -
Net Income in Millions -37 -30 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -22.25 % -23.6 % - - -

Back to NITE Management Effectiveness >> NITE's 5 Years Annual ROE >> Compare NITE ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NITE's' Return on Equity at Yahoo Finance
NITE's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NITE's Competitors
Subscribers only: Roe for Nightstar Therapeutics Plc's Suppliers
Subscribers only: Return On Equity for NITE's Customers




Companies with similar Return On Equity at Mar 31 2019, within Healthcare Sector ROE

Date modified: 2026-09-08T21:14:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.